Concepedia

Andrea T. Hooper

AT

62

Publications

11.6K

Citations

39

H-Index

1999

Active since

Affiliations

Regeneron (United States)(Current)

Cornell University

Howard Hughes Medical Institute

Pfizer (United States)

University of Washington

Andrea T. Hooper is an author at Regeneron (United States) specializing in medicine, cell biology, and immunology.

ORCID

Top concepts

Publications per year

1999–2024

62

Publications

62

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

David M. Weinreich, Sumathi Sivapalasingam, Thomas Norton et al. · New England Journal of Medicine · 2020 · 1.8K citations · Full text

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

Aernout Luttun, Marc Tjwa, Lieve Moons et al. · Nature Medicine · 2002 · 1.1K citations · Full text

, , +12

CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors

Sergey V. Shmelkov, Jason M. Butler, Andrea T. Hooper et al. · Journal of Clinical Investigation · 2008 · 889 citations · Full text

, , +14

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

Marie Prewett, JC Huber, Yiwen Li et al. · PubMed · 1999 · 660 citations

, , +18

Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells

Jason M. Butler, Daniel J. Nolan, Eva Vertes et al. · Cell stem cell · 2010 · 658 citations · Full text

, , +6

Rows per page

1–5 of 62